USD 17.5
(-4.06%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 328.84 Million USD | 5.09% |
2022 | 312.91 Million USD | 1.99% |
2021 | 306.8 Million USD | 78.9% |
2020 | 171.49 Million USD | 37.13% |
2019 | 125.05 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q3 | 98.51 Million USD | 4.4% |
2024 Q1 | 96.48 Million USD | 7.76% |
2024 Q2 | 94.35 Million USD | -2.21% |
2023 Q3 | 88.58 Million USD | 17.5% |
2023 FY | 328.84 Million USD | 5.09% |
2023 Q4 | 89.53 Million USD | 1.07% |
2023 Q2 | 75.39 Million USD | 0.09% |
2023 Q1 | 75.32 Million USD | -14.32% |
2022 Q1 | 78.24 Million USD | -4.78% |
2022 FY | 312.91 Million USD | 1.99% |
2022 Q4 | 87.91 Million USD | 8.66% |
2022 Q3 | 80.9 Million USD | 22.86% |
2022 Q2 | 65.85 Million USD | -15.84% |
2021 FY | 306.8 Million USD | 78.9% |
2021 Q4 | 82.16 Million USD | 1.54% |
2021 Q3 | 80.92 Million USD | 7.82% |
2021 Q2 | 75.05 Million USD | 9.33% |
2021 Q1 | 68.65 Million USD | 24.39% |
2020 Q3 | 42.72 Million USD | 14.78% |
2020 Q2 | 37.22 Million USD | 2.4% |
2020 Q4 | 55.19 Million USD | 29.17% |
2020 Q1 | 36.35 Million USD | 0.0% |
2020 FY | 171.49 Million USD | 37.13% |
2019 FY | 125.05 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Clover Health Investments, Corp. | 1.98 Billion USD | 83.434% |
Marpai, Inc. | 35.39 Million USD | -829.156% |
NewGenIvf Group Limited | 2.52 Million USD | -12941.204% |